Bioassay DNA In-Vivo Scientist 
Drug Discovery World
NOVEMBER 9, 2023
Klaus Wagenbauer, PhD, Founder & CEO, Plectonic, on: ‘Programmable DNA-origami-based T cell engagers: PTE’. Gail Calvert, Field Application Scientist, Sartorius UK, on: ‘Leveraging integrated and advanced technologies for successful cell line development’. Croasdale-Wood will then participate in a keynote chat, interviewed by Miho.
Drug Discovery World
NOVEMBER 30, 2023
DDW’s Megan Thomas attended PEGS Europe 2023 in Lisbon, Portugal, from Tuesday 14 November to Thursday 16 November 2023. The company’s goal is to accelerate functional characterisation and shortenoptimisation time in antibody discovery and t-cell workflows. GSK has developed high-throughput mammalian and E.
Expert insights. Personalized for you.
52 
Let's personalize your content